Cancel

Request a live demo presentation

One of our sales representative will call you soon


By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

We have generated thousand of leads for our happy customers

  • company
  • company
  • company
  • company
  • company
  • company
  • company
  • company

Eurofins Genomics Europe Pharma and Diagnostics Products & Services Synthesis GmbH Active

Scientific & Education


Contact information


Unlock Company Insights Free Access

Get instant access to key company data, decision-maker contacts, and verified insights.

Book a Demo now

Financial statements of Eurofins Genomics Europe Pharma and Diagnostics Products & Services Synthesis GmbH

According to Eurofins Genomics Europe Pharma and Diagnostics Products & Services Synthesis GmbH latest financial report submitted on 2023-12-31, the company has a Gross-Profit of €9M, Total-Assets of €19M while the Total-Liabilities is €17M. Compared with the previous year, the company reported a Gross-Profit increase of 0.0%, which is an equivalent of 8.8 million. At the same time, the Total-Assets went up by 71.12%, or by 33.2 million.


Year:
2022 Not available
2021 Not available
2020 Not available
2019 Not available

Access 20 Years of Financial Data

Book a Demo
  • Consolidated A/cs

    N

  • Profit after Tax

    € -1

Total Assets

Business Credit Report

A Credit Report Eurofins Genomics Europe Pharma and Diagnostics Products & Services Synthesis GmbH is available for instant download. When we generate this report, we took into account that the company is 18 year old, Gross-Profit €9M, Total-Assets €19M and the Total-Liabilities of €17M. Next, we took into account if there are any outstanding mortgages or Court Judgements and checked if the industry which the company is trading, is considered a high level of corporate failures.


Overall Credit Risk for

Eurofins Genomics Europe Pharma and Diagnostics Products & Services Synthesis GmbH

Unlock Credit Report

For more information you can

Key features

  • Credit Score and Credit Limit
  • Financial accounts for the past 5 years
  • Credit Officers
  • Document Filing history
  • Corporate Ownership
  • Outstanding & Satisfied Mortgages
  • Shareholder Information
  • Company Identity

Employees

Eurofins Genomics Europe Pharma and Diagnostics Products & Services Synthesis GmbH currently employees 14 people. The management level consists of 14.29% of manager level, 0.00% of senior level, 0.00% of cxo level, 85.71% of director level, 0.00% of vp level, 0.00% of partner level, 0.00% of non-manager level.


Total Employee Count

Total employees

14

Management Level


86

Middle

14

Operational

Employee Job Title Email Phone Country
Peter Persigehl Managing Director
-
- DE
Daniela Katarzynski Managing Director
-
- DE
Sonja Wiedemann Managing Director
-
- DE
Hadem Michael Managing Director
-
- DE
Bruno Poddevin Managing Director
-
- DE

Get direct emails & phone numbers for senior executives working at «Eurofins Genomics Europe Pharma and Diagnostics Products & Services Synthesis GmbH»

Build your list of contacts and filter them by job title seniority level, age nationality and export the list to XL, Salesforce or via API

Install Free Browser Extension

Group Structure

Explore the Full Corporate Tree.

Uncover parent companies, subsidiaries, and global linkages

Book a Demo

Eurofins Genomics Europe Pharma and Diagnostics Products & Services Synthesis GmbH Shareholders and Ultimate Beneficial Owners (UBO)

See All Beneficial Owners & Shareholders

Unlock Full Access For Free

Eurofins Genomics Europe Pharma and Diagnostics Products & Services Synthesis GmbH news & activities:


Stay Ahead with Real-Time Insights

Monitor key metrics and company activity

Book a Demo

Frequently Asked Questions regarding Eurofins Genomics Europe Pharma and Diagnostics Products & Services Synthesis GmbH


Where is Eurofins Genomics Europe Pharma and Diagnostics Products & Services Synthesis GmbH registered office?

Eurofins Genomics Europe Pharma and Diagnostics Products & Services Synthesis GmbH is located at Anzinger Straße 7 A, Germany.

How can I contact Eurofins Genomics Europe Pharma and Diagnostics Products & Services Synthesis GmbH?

You can call Eurofins Genomics Europe Pharma and Diagnostics Products & Services Synthesis GmbH at the following number +498092*****

What is the website of Eurofins Genomics Europe Pharma and Diagnostics Products & Services Synthesis GmbH?

Eurofins Genomics Europe Pharma and Diagnostics Products & Services Synthesis GmbH website is https://eurofins.com/

How many people work at Eurofins Genomics Europe Pharma and Diagnostics Products & Services Synthesis GmbH?

According to the latest account statement, there are currently 14 of employees working for Eurofins Genomics Europe Pharma and Diagnostics Products & Services Synthesis GmbH.

What is the Business Credit Score of Eurofins Genomics Europe Pharma and Diagnostics Products & Services Synthesis GmbH and how reliable is the company?

In order to check the business credit score of Eurofins Genomics Europe Pharma and Diagnostics Products & Services Synthesis GmbH, you can request a credit report. You will view the latest credit limit information, ownership, group structure, court judgements and much more.

Does Eurofins Genomics Europe Pharma and Diagnostics Products & Services Synthesis GmbH pay their invoices on time?

By requesting a Business Credit Report for Eurofins Genomics Europe Pharma and Diagnostics Products & Services Synthesis GmbH, you will be able to gain more insights about the Eurofins Genomics Europe Pharma and Diagnostics Products & Services Synthesis GmbH payment trends.

Access 100% verified registry data via API—company profiles, group structures, UBOs, financials, and more.

Get Free API Access

Search for International Credit Report

0 results
Name
Arrow Arrow
City
Arrow Arrow
Address
Arrow Arrow
Reg. No
Arrow Arrow
Status
Arrow Arrow
Action